Advertisement

Topics

Ferrer Group Inc. Company Profile

03:57 EDT 4th May 2016 | BioPortfolio

Ferrer Grupo offers products of a high scientific standard, according to client needs, together with health training programmes which provide up-to-date information on the constant improvements in the fields of medicine and pharmacology, and maintain direct contact with health professionals, patients and the general public.

Location

Edifici L'illaDiagonal, 549 5a planta
Barcelona
E-08029
Spain

Contact

Phone: 34 93 600 37 00
Fax: 34 93 490 70 78
Email: medicaldepartment@ferrergrupo.com


News Articles [381 Associated News Articles listed on BioPortfolio]

Alexza Pharmaceuticals (ALXA) - Ferrer signals intent to potentially buy company

Edison Investment Research - Pharmaceutical & Healthcare - Alexza Pharmaceuticals: Alexza disclosed on 26 February that it had entered into a non-binding letter of intent (LOI) from Ferrer on 15 Febru...

Alexza Confirms Grupo Ferrer Non-binding Letter of Intent

NewsAlexza Pharmaceuticals confirms entering into a non-binding letter of intent with Grupo Ferrer Internacional, S.A. with respect to Ferrer's proposed acquisition of all outstanding common shares ...

Grupo Ferrer to acquire Alexza

Per a non-binding letter of intent, private Spanish company Grupo Ferrer Internacional SA aims to acquire all shares of public US biotech Alexza Pharmaceuticals Inc. (CNS therapeutics) that it doesn't...

Alexza Pharma confirms takeover talks with Grupo Ferrer

US drugmaker Alexza Pharmaceuticals confirmed that it had entered into a non-binding letter of intent…

Alexza Pharmaceuticals Confirms Grupo Ferrer Non-binding Letter of Intent

MOUNTAIN VIEW, Calif., Feb. 26, 2016 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA, "Alexza, or the "Company') announced today that on February 15, 2016 it had entered into a non-bin...

Boeing und Airbus Group vs. Kuoni und TUI AG - kommentierter KW 43 Peer Group Watch Luftfahrt & Reise

In der Wochensicht ist vorne: Boeing 6,61% vor Airbus Group 5,53%, Flughafen Wien 4,44%, FACC 4,26%, Fraport 3,48%, Thomas Cook Group 2,91%, Lufthansa 2,24%, Air Berlin 2,14%, TUI AG 2,06% und Kuon...

TUI AG und Thomas Cook Group vs. FACC und Boeing - kommentierter KW 13 Peer Group Watch Luftfahrt & Reise

In der Wochensicht ist vorne: TUI AG 8,65% vor Thomas Cook Group 4,21%, Air Berlin 1,02%, Lufthansa 0,25%, Fraport -0,15%, Flughafen Wien -0,33%, Kuoni -0,82%, Airbus Group -2,71%, Boeing -3,91% un...

Lufthansa und Kuoni vs. Boeing und Airbus Group - kommentierter KW 1 Peer Group Watch Luftfahrt & Reise

In der Wochensicht ist vorne: Lufthansa 2,44% vor Kuoni 0,54%, TUI AG -0,98%, Thomas Cook Group -1,65%, Air Berlin -1,75%, FACC -2,69%, Flughafen Wien -4,68%, Fraport -4,92%, Airbus Group -6,96% un...

PubMed Articles [2413 Associated PubMed Articles listed on BioPortfolio]

The Fuster-CNIC-Ferrer Cardiovascular Polypill: a polypill for secondary cardiovascular prevention.

During the last decade, there has been a tremendous effort to develop different cardiovascular polypills in response to the upsurge in global cardiovascular disease worldwide. The pharmacological deve...

Improvement of the Marginal Reflex Distance-1 in Blepharoptosis Surgeries.

The aim of this study was to predict the improvement of the marginal reflex distance (MRD1) in each blepharoptosis surgery.In PubMed and Scopus, the search terms 1. (blepharoptosis) AND 2. (surgery) A...

I won't tell: Young children show loyalty to their group by keeping group secrets.

Group loyalty is highly valued. However, little is known about young children's loyal behavior. This study tested whether 4- and 5-year-olds (N=96) remain loyal to their group even when betraying it w...

"Echocardiographic abnormalities in patients with COPD at their first hospital admission." Xavier Freixa, Karina Portillo, Carles Paré, Judith Garcia-Aymerich, Federico P. Gomez, Marta Benet, Josep Roca, Eva Farrero, Jaume Ferrer, Carlos Fernandez-Palomeque, Josep M. Antó and Joan Albert Barberà, on behalf of the PAC-COPD Study Investigators. Eur Respir J 2013; 41: 784-791.

Three new species of Macrelmis Motschulsky (Coleoptera: Elmidae: Elminae) from Southeastern Brazil with new definition of species groups to the genus.

Three new species of Macrelmis Motschulsky, 1859 are described and illustrated based on adult males from Rio de Janeiro, Minas Gerais and São Paulo states (southeastern Brazil). A new species groups ...

Clinical Trials [2164 Associated Clinical Trials listed on BioPortfolio]

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Electro-acupuncture and Flumazenil's Effect on Sedation

Object: To explore the mechanism of the electro-acupuncture (EA) induced sedation effect in general anaesthesia through investigating the role of the Benzodiazepines-GABA system. Method: ...

Does Cognitive Rehabilitation Demonstrate Benefits in the Group Setting With People Whom Have Experienced Brain Injury?

The purpose of this study is to determine whether there is benefit from providing cognitive rehabilitation in the group setting. Several standardized tools will be used to measure progres...

Short Term Group Therapy for OCD

Assessing OCD before and after group therapy

Early Group Based Parental Support Within Child Health Service - Group Leadership

All parents in Sweden are offered group based parental support within Child Health Service (CHS) but only 40% participate. Nurses feel insecure in their group leadership and express a need...

Companies [1536 Associated Companies listed on BioPortfolio]

Ferrer Group Inc.

Ferrer Grupo offers products of a high scientific standard, according to client needs, together with health training programmes which provide up-to-date information on the constant improvements in the...

Ferrer Freeman & Company, LLC

Ferrer Freeman & Company, LLC, is a private equity firm located in Greenwich, CT focuses exclusively on growth capital investments in the healthcare industry. Since its founding i...

DiaGenic ASA & Ferrer inCode

DiaGenic is an innovative Norwegian biotechnology company that seeks to create value for patients, partners, and investors by developing new and more patient friendly methods for ...

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

PharmEvo (Pvt.) Ltd.

PharmEvo is backed by a reputable corporate group with a history of successful business ventures spread over 30 years. The group made its debut in 1971, with the sales and marketing of prestigious bra...

More Information about "Ferrer Group Inc." on BioPortfolio

We have published hundreds of Ferrer Group Inc. news stories on BioPortfolio along with dozens of Ferrer Group Inc. Clinical Trials and PubMed Articles about Ferrer Group Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ferrer Group Inc. Companies in our database. You can also find out about relevant Ferrer Group Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record